临床荟萃
臨床薈萃
림상회췌
Clinical Focus
2015年
12期
1417-1420
,共4页
肾病综合征%肾小球肾炎,膜性%他克莫司
腎病綜閤徵%腎小毬腎炎,膜性%他剋莫司
신병종합정%신소구신염,막성%타극막사
nephrotic syndrome%glomerulonephritis,membranous
目的:观察长疗程他克莫司联合小剂量激素治疗特发性膜性肾病的疗效和安全性。方法选择常州第一人民医院2012年3月至2015年5月经肾穿刺活检确诊为特发性膜性肾病的患者54例,随机分为短疗程组27例和长疗程组27例,短疗程组给予激素联合他克莫司治疗12个月,长疗程组治疗24个月,观察两组的疗效、安全性及复发等情况。结果5例患者因发生严重不良反应退出研究。短疗程组24例,6例获得完全缓解,12例部分缓解,6例无效;治疗结束后6例复发。长疗程组25例,10例获得完全缓解,13例获得部分缓解,2例无效;治疗结束后2例复发。结论长疗程他克莫司联合小剂量激素可有效治疗特发性膜性肾病,缓解率更高,且复发率低。
目的:觀察長療程他剋莫司聯閤小劑量激素治療特髮性膜性腎病的療效和安全性。方法選擇常州第一人民醫院2012年3月至2015年5月經腎穿刺活檢確診為特髮性膜性腎病的患者54例,隨機分為短療程組27例和長療程組27例,短療程組給予激素聯閤他剋莫司治療12箇月,長療程組治療24箇月,觀察兩組的療效、安全性及複髮等情況。結果5例患者因髮生嚴重不良反應退齣研究。短療程組24例,6例穫得完全緩解,12例部分緩解,6例無效;治療結束後6例複髮。長療程組25例,10例穫得完全緩解,13例穫得部分緩解,2例無效;治療結束後2例複髮。結論長療程他剋莫司聯閤小劑量激素可有效治療特髮性膜性腎病,緩解率更高,且複髮率低。
목적:관찰장료정타극막사연합소제량격소치료특발성막성신병적료효화안전성。방법선택상주제일인민의원2012년3월지2015년5월경신천자활검학진위특발성막성신병적환자54례,수궤분위단료정조27례화장료정조27례,단료정조급여격소연합타극막사치료12개월,장료정조치료24개월,관찰량조적료효、안전성급복발등정황。결과5례환자인발생엄중불량반응퇴출연구。단료정조24례,6례획득완전완해,12례부분완해,6례무효;치료결속후6례복발。장료정조25례,10례획득완전완해,13례획득부분완해,2례무효;치료결속후2례복발。결론장료정타극막사연합소제량격소가유효치료특발성막성신병,완해솔경고,차복발솔저。
ABSTRACT:Objective To observe therapeutic effect and safety of prolonged tacrolimus combined with small dose of hormone on idiopathic membranous nephropathy (IMN )with nephrotic syndrome in different courses of treatment.Methods A total of 54 patients with IMN were randomly divided into short-term (n =27)and long-term ( n =27)groups.All patients received initial treatment with tacrolimus and prednisone for 6 months,and afterward tapered with low-dose tacrolimus until 12 months (short-term )and 24 months (long-term ).Treatment effects, recurrence and side effects were observed in two groups.Results Five patients quitted study due to severe side effects. Six patients obtained complete remission and 12 patients obtained partial remission after 12 months of treatment in the short-term group;6 patients had no response.10 patients obtained complete remission and 13 patients obtained partial remission after 24 months of treatment in the long-term group;One patient had no response.Six patients relapsed in the short-term group after tacrolimus withdrawal,while only two patients suffered from recurrence in the long-term group.Conclusion Prolonged tacrolimus combined with prednisone can relieve IMN significantly with lower recurrence rate.